July -
- Net sales amounted to
SEK 0 (0). -
Operating profit amounted to
SEK 240,145 (237,140). - Profit per average number of shares after tax amounted to 0.01 (0.01)
January -
- Net sales amounted to
SEK 0 (0). -
Operating profit amounted to
SEK -3,108,861 (-2,317,061) - Profit per average number of shares after tax amounted to -0.10 (-0.15)
The report is published at www.clinescientific.com/financial-reports
For more information, please contact:
Email: patrik.sundh@clinescientific.com
Phone: +46 703-585 088
The company is listed on the Nasdaq First North Growth Market.
Pepparedsleden 1
AstraZeneca BioVentureHub Email: info@clinescientific.com
431 53 MÖLNDAL Website: www.clinescientific.com
About
https://news.cision.com/cline/r/bokslutskommunike-for-cline-scientific-ab--publ--556867-8238--for-the-period-1-january---31-december,c3934414
https://mb.cision.com/Main/12114/3934414/2623749.pdf
(c) 2024 Cision. All rights reserved., source